Gene Transactivation and Transrepression in MYC-Driven Cancers

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• The MYC proto-oncogene plays a critical role in regulating cellular functions.
• MYC deregulation, through increased gene expression or protein stability, is a hallmark of cancer.
• Overexpression of MYC promotes stem cell self-renewal and inhibits senescence and differentiation, contributing to malignant growth.

Purpose of the Study:

• To review recent advances in understanding MYC-mediated molecular mechanisms in oncogenesis.
• To highlight MYC's role as a regulator of the cancer genome and epigenome.
• To discuss emerging therapeutic strategies targeting MYC and its cofactors.

Main Methods:

• Literature review of recent findings on MYC's oncogenic activity.
• Analysis of MYC's mechanisms in modulating gene expression and chromatin structure.
• Synthesis of information on novel therapeutic approaches.

Main Results:

• MYC modulates target gene expression site-specifically by recruiting chromatin remodelers.
• MYC regulates epigenetic modifiers, impacting genome-wide chromatin structure.
• Recent findings underscore MYC's dual role in regulating both the cancer genome and epigenome.

Conclusions:

• MYC's oncogenic activity is driven by its profound effects on gene regulation and epigenetic modifications.
• Understanding these mechanisms is crucial for developing effective cancer therapies.
• Targeting MYC directly or its epigenetic cofactors represents a promising therapeutic avenue.